Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Post-merger, gene therapy player Adverum makes Amber Salzman CEO, delays a clinical trial start
9 years ago
R&D
The Sarepta dilemma: Bioethics expert Arthur Caplan says it’s time to rethink how to regulate compassion
9 years ago
Pharma
Can We Conquer All Diseases By The End Of The Century? An Interview with Chan Zuckerberg's Cori Bargmann.
9 years ago
André Choulika on gene editing: "If you marry yourself to a technology, you're doomed."
9 years ago
Presto! Wall Street magician Vivek Ramaswamy has another instant biotech IPO to sell you
9 years ago
Financing
UniQure CEO Soland makes a quick exit as execs hammer out a new strategy
9 years ago
Pharma
Long-suffering Eleven hands the reins over to a new CEO with his own pipeline plans
9 years ago
Pharma
GSK makes a little history while outlining a familiar future
9 years ago
Bioregnum
Opinion
Yale’s David Spiegel inspires another immuno-oncology R&D spinout focused on Antibody Recruiting Molecules
9 years ago
R&D
Roger Tsien, 1952-2016: “I’ve always been attracted to colors”
9 years ago
$354M exit package in hand, Medivation CEO David Hung completes a master class in biotech auctions
9 years ago
Pharma
Martin Shkreli, the obscene prankster of biotech, makes his final exit at KaloBios
9 years ago
Pharma
Mylan CEO Bresch hopes to tame the mob with a 50% discount for the EpiPen
9 years ago
Pharma
Bind burial complete, Andrew Hirsch lands the CFO’s job at high-profile Agios
9 years ago
Pharma
Ex-Allergan CEO David Pyott backs a biotech startup alongside Takeda, PhI trial set to launch
9 years ago
Startups
R&D
Martin Shkreli will have his day(s) in court - next June
9 years ago
Ex-Biogen exec Steve Holtzman hears the call of Third Rock’s ambitious Decibel
9 years ago
Startups
Ebola! Zika! ATM! Inovio CEO Kim called out for gaming pandemic panic
9 years ago
Pharma
Gary Glick gets $27M to leap back into immuno-oncology R&D with Novartis, Atlas and Abingworth in his corner
9 years ago
R&D
Sean Parker finds a big role to play in cancer R&D: The disruptive billionaire
9 years ago
R&D
First page
Previous page
98
99
100
101